ChemoCentryx, Inc. Deferred Revenue Recognized
ChemoCentryx, Inc. reported Deferred Revenue Recognized of $2.48 million for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2022-08-08
- ChemoCentryx, Inc. contract with customer, liability, revenue recognized for the quarter ending 2022-06-30 was $2.48M, a 50.21% increase year-over-year.
- ChemoCentryx, Inc. contract with customer, liability, revenue recognized for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- ChemoCentryx, Inc. contract with customer, liability, revenue recognized for the quarter ending 2021-09-30 was $17.68M, a 255.99% increase year-over-year.
- ChemoCentryx, Inc. contract with customer, liability, revenue recognized for the quarter ending 2021-06-30 was $1.65M, a 96.64% decline year-over-year.
- ChemoCentryx, Inc. contract with customer, liability, revenue recognized for fiscal 2021 was $30.82M, a 52.03% decline from fiscal 2020.
- ChemoCentryx, Inc. contract with customer, liability, revenue recognized for fiscal 2020 was $64.25M, a 79.56% increase from fiscal 2019.
- ChemoCentryx, Inc. contract with customer, liability, revenue recognized for fiscal 2019 was $35.78M, a 10.13% decline from fiscal 2018.
- ChemoCentryx, Inc. contract with customer, liability, revenue recognized for fiscal 2018 was $39.81M.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 6 month as first filed | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|---|
| 2022-06-30 | $2.48M 10-Q · filed 2022-08-08 | $2.48M 10-Q · filed 2022-08-08 | |||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-10 | ||||
| 2021-12-31 | $30.82M 10-K · filed 2022-03-01 | ||||
| 2021-09-30 | $17.68M 10-Q · filed 2021-11-09 | $29.55M 10-Q · filed 2021-11-09 | |||
| 2021-06-30 | $1.65M 10-Q · filed 2021-08-09 | $11.86M 10-Q · filed 2021-08-09 | |||
| 2021-03-31 | $10.21M 10-Q · filed 2022-05-10 | ||||
| 2020-12-31 | $64.25M 10-K · filed 2022-03-01 | ||||
| 2020-09-30 | $4.97M 10-Q · filed 2020-11-09 | $60.03M 10-Q · filed 2020-11-09 | |||
| 2020-06-30 | $49.23M 10-Q · filed 2020-08-10 | ||||
| 2020-03-31 | $5.84M 10-Q · filed 2021-05-03 | ||||
| 2019-12-31 | $35.78M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $10.58M 10-Q · filed 2019-11-04 | $25.91M 10-Q · filed 2019-11-04 | |||
| 2019-06-30 | $7.17M 10-Q · filed 2019-08-05 | $55.07M 10-Q · filed 2020-08-10 | $15.33M 10-Q · filed 2019-08-05 | ||
| 2019-03-31 | $8.16M 10-Q · filed 2020-05-11 | ||||
| 2018-12-31 | $39.81M 10-K · filed 2021-03-01 |